← back to search

Kathryn L. Pellegrini

Emory University · US
Area of research
Infectious Diseases · Neurology
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, and Immune responses and vaccinations.
h-index
23
citations
3,849
works
55
NIH funding
primary concept
Biology
email

Recent publications

Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients
Nature Communications 2025cited by 5position: middledoi
Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth
Cell 2023cited by 65position: middledoi
TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques
Nature Communications 2023cited by 37position: middledoi
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
Science Immunology 2023cited by 28position: middledoi
Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life
medRxiv 2023cited by 2position: middledoi
Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Nature 2021cited by 563position: middledoi
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Immunity 2021cited by 91position: middledoi
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Science 2020cited by 1,334position: middledoi
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
Journal of Virology 2020cited by 329position: middledoi
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
Cell 2020cited by 224position: middledoi
Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques
Cell 2020cited by 210position: middledoi
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
British Journal of Urology 2019cited by 39position: middledoi
Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer
Cancers 2018cited by 44position: middledoi
Detection of prostate cancer‐specific transcripts in extracellular vesicles isolated from post‐DRE urine
The Prostate 2017cited by 33position: firstdoi
Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation
Proceedings of the National Academy of Sciences 2014cited by 334position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Martin G. Sanda · Emory University3 papers (2014–2019)Carlos S. Moreno · Emory University2 papers (2017–2018)Dattatraya Patil · Emory University2 papers (2017–2019)Jeremy Clark · University of Alabama at Birmingham2 papers (2017–2019)Abigail Vanderheiden · Emory University1 papers (2020–2020)Eric J. Sorscher · Emory University1 papers (2020–2020)Fred Saad · Cytodiagnostics (Canada)1 papers (2018–2018)Sungyong You · Kyung Hee University Medical Center1 papers (2018–2018)John A. Petros · Emory University1 papers (2018–2018)Felipe Giuste · Georgia Institute of Technology1 papers (2018–2018)Pei‐Yong Shi · First Affiliated Hospital of Nanchang University1 papers (2020–2020)Jacob E. Kohlmeier · Emory University1 papers (2020–2020)Gregory M. Tharp · Emory University1 papers (2020–2020)Vineet D. Menachery · Emory University1 papers (2020–2020)Kristen Douglas · VIR Biotechnology (United States)1 papers (2017–2017)Hadj Aoued · Emory National Primate Research Center1 papers (2020–2020)Haydn Kissick · Emory University1 papers (2014–2014)Hardev Pandha · Yale Cancer Center1 papers (2019–2019)Tatiana Chirkova · Emory University1 papers (2020–2020) · 1 papers (2019–2019)